Cargando…
Strong Medicine : Creating Incentives for Pharmaceutical Research on Neglected Diseases /
"Vaccines offer the best hope for controlling diseases and could dramatically improve health in poor countries. But developers have little incentive to undertake the costly and risky research needed to develop vaccines. This is partly because the potential consumers are poor, but also because g...
| Autor principal: | |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Princeton, NJ :
Princeton University Press,
2004.
|
| Colección: | Book collections on Project MUSE.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a22000004a 4500 | ||
|---|---|---|---|
| 001 | musev2_47699 | ||
| 003 | MdBmJHUP | ||
| 005 | 20230905044947.0 | ||
| 006 | m o d | ||
| 007 | cr||||||||nn|n | ||
| 008 | 160505s2004 nju o 00 0 eng d | ||
| 020 | |a 9781400880140 | ||
| 020 | |z 9780691171166 | ||
| 020 | |z 9780691121130 | ||
| 035 | |a (OCoLC)966768856 | ||
| 040 | |a MdBmJHUP |c MdBmJHUP | ||
| 100 | 1 | |a Kremer, Michael, |d 1964- | |
| 245 | 1 | 0 | |a Strong Medicine : |b Creating Incentives for Pharmaceutical Research on Neglected Diseases / |c Michael Kremer and Rachel Glennerster. |
| 264 | 1 | |a Princeton, NJ : |b Princeton University Press, |c 2004. | |
| 264 | 3 | |a Baltimore, Md. : |b Project MUSE, |c 2017 | |
| 264 | 4 | |c ©2004. | |
| 300 | |a 1 online resource (152 pages): |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 505 | 0 | |a Cover ; Title ; Copyright ; Dedication ; CONTENTS ; Foreword ; Acknowledgments ; 1. INTRODUCTION ; 2. HEALTH IN LOW-INCOME COUNTRIES ; The Disease Environment in Low-Income Countries ; Weak Health-Care Infrastructure ; Malaria, Tuberculosis, and HIV/AIDS. | |
| 505 | 0 | |a The Impact of Cheap, Simple Technologies 3. THE PAUCITY OF PRIVATE R & D TARGETED TO THE NEEDS OF LOW-INCOME COUNTRIES ; The Extent of R & D Targeted to Low-Income Countries ; The Scientific Potential for New Vaccines ; 4. MARKET AND GOVERNMENT FAILURES. | |
| 505 | 0 | |a Why Target Foreign Assistance to Vaccine R & D? The Patent Tradeoff ; Low-Income Countries and Intellectual Property ; Social versus Private Return: Some Quantitative Estimates ; The Role of Public Purchases ; 5. THE ROLE OF PUSH PROGRAMS. | |
| 505 | 0 | |a Meningococcal Meningitis: An Example of a Successful Push Program A Cautionary Tale: The USAID Malaria Vaccine Program ; Incentives under Push Programs ; 6. THE POTENTIAL ROLE OF PULL PROGRAMS ; The Effect of Market Size on Innovation ; The Impact of Financial Incentive Programs. | |
| 505 | 0 | |a Examples of Pull Programs Stimulating Research Advantages and Limitations of Pull Programs ; 7. PULL PROGRAMS: A MENU ; Commitments to Finance Purchase of Products and Patents ; Patent Extensions on Other Pharmaceuticals as Compensation for Vaccine Development ; Best-Entry Tournaments. | |
| 520 | 1 | |a "Vaccines offer the best hope for controlling diseases and could dramatically improve health in poor countries. But developers have little incentive to undertake the costly and risky research needed to develop vaccines. This is partly because the potential consumers are poor, but also because governments drive down prices." "In Strong Medicine, Michael Kremer and Rachel Glennerster offer an innovative yet simple solution to this worldwide problem: "Pull" programs to stimulate research. Here's how such programs would work. Funding agencies would commit to purchase viable vaccines if and when they were developed. This would create the incentives for vaccine developers to produce usable products for these neglected diseases. Private firms, rather than funding agencies, would pick which research strategies to pursue. After purchasing the vaccine, funders could distribute it at little or no cost to the afflicted countries."--Jacket | |
| 588 | |a Description based on print version record. | ||
| 650 | 1 | 7 | |a Keuzes. |2 gtt |
| 650 | 1 | 7 | |a Onderzoek. |2 gtt |
| 650 | 1 | 7 | |a Farmaceutische industrie. |2 gtt |
| 650 | 7 | |a Forschungsfinanzierung |2 gnd | |
| 650 | 7 | |a Forschungsförderung |2 gnd | |
| 650 | 7 | |a Arzneimittelforschung |2 gnd | |
| 650 | 7 | |a Gesundheitsförderung |2 gnd | |
| 650 | 7 | |a Pharmacy |x Research |x Economic aspects. |2 fast |0 (OCoLC)fst01060317 | |
| 650 | 7 | |a Drugs |x Research |x Economic aspects. |2 fast |0 (OCoLC)fst00898899 | |
| 650 | 7 | |a BUSINESS & ECONOMICS |x Economics |x Theory. |2 bisacsh | |
| 650 | 7 | |a POLITICAL SCIENCE |x Public Policy |x Social Services & Welfare. |2 bisacsh | |
| 650 | 7 | |a POLITICAL SCIENCE |x Public Policy |x Social Security. |2 bisacsh | |
| 650 | 7 | |a research (function) |2 aat | |
| 650 | 6 | |a Vaccins. | |
| 650 | 6 | |a Recherche. | |
| 650 | 6 | |a Medicaments. | |
| 650 | 6 | |a Pharmacoeconomie. | |
| 650 | 0 | 2 | |a Vaccines |
| 650 | 0 | 2 | |a Research |
| 650 | 0 | 2 | |a Research Support |
| 650 | 0 | 2 | |a Pharmaceutical Preparations |
| 650 | 0 | 2 | |a Economics, Pharmaceutical |
| 650 | 0 | 2 | |a Developing Countries |
| 650 | 0 | |a Vaccines. | |
| 650 | 0 | |a Research. | |
| 650 | 0 | |a Drugs. | |
| 650 | 0 | |a Vaccines |x Research |x Economic aspects |z Developing countries. | |
| 650 | 0 | |a Drugs |x Research |x Economic aspects |z Developing countries. | |
| 650 | 0 | |a Pharmacy |x Research |x Economic aspects |z Developing countries. | |
| 651 | 7 | |a Entwicklungsländer |2 gnd | |
| 651 | 7 | |a Developing countries. |2 fast |0 (OCoLC)fst01242969 | |
| 655 | 7 | |a Electronic books. |2 local | |
| 700 | 1 | |a Glennerster, Rachel. | |
| 710 | 2 | |a Project Muse. |e distributor | |
| 830 | 0 | |a Book collections on Project MUSE. | |
| 856 | 4 | 0 | |z Texto completo |u https://projectmuse.uam.elogim.com/book/47699/ |
| 945 | |a Project MUSE - Custom Collection | ||
| 945 | |a Project MUSE - Archive Complete Supplement V | ||
| 945 | |a Project MUSE - Archive Political Science and Policy Studies Supplement V | ||